Hong Li

Interim Clinical Director at CLab Oncology

Hong Li has over 20 years of extensive global clinical development and medical affairs strategic experience, outstanding proven track records in US, Europe, and Asian-pacific. As a clinical/medical/project lead, led global cross function teams to develop clinical and/or medical plans, conduct international trials across multiple therapeutic indications and cross phases 1-4 and postmarketing, to meet scientific, regulatory and commercial needs, with high quality and in a timely/on budget/scientifically responsible fashion.

Timeline

  • Interim Clinical Director

    Current role